C4 Therapeutics vs Caris Life Sciences
C4 Therapeutics vs Caris Life Sciences, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: C4 Therapeutics is on 49/100 and Caris Life Sciences on 59/100.
Where each one leads
C4 Therapeutics
Leads on none of the measures we hold for both companies.
Caris Life Sciences
- our overall score: 59/100 against 49/100
- agent readiness: 47/100 against 21/100
- domain rating: 63/100 against 41/100
- funding raised: $700M against $371M
At a glance
| Measure | C4 Therapeutics | Caris Life Sciences |
|---|---|---|
| What it is | Biopharmaceutical company developing novel cancer therapies using targeted protein degradation. | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. |
| Category | Biotech, Drug Discovery, Oncology, Clinical Trials | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2016 | 2008 |
| Headquarters | Boston, United States | Irving, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | C4 Therapeutics | Caris Life Sciences |
|---|---|---|
| Employees | Not published | 1,659 |
| Total funding | $371M | $700M |
| Latest round | Series D | Series D |
| Valuation | Not published | $7.8B |
| LinkedIn followers | Not published | 77,698 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | C4 Therapeutics | Caris Life Sciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 49/100 | 59/100 |
| Traction | 40/100 | 60/100 |
| Team | 20/100 | Not published |
| Search visibility | 3/100 | 22/100 |
| Quality | 68/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 41/100 | 63/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | C4 Therapeutics | Caris Life Sciences |
|---|---|---|
| Hosting | Google Cloud | Self Managed |
| CMS | WordPress | WordPress |
| Analytics | Google Analytics 4, Google Tag Manager | Google Tag Manager |
C4 Therapeutics vs Caris Life Sciences: common questions
Which is better, C4 Therapeutics or Caris Life Sciences?
On our 0-100 score Caris Life Sciences rates higher (59/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do C4 Therapeutics and Caris Life Sciences compare on the numbers?
Caris Life Sciences leads on our overall score (59/100 against 49/100), agent readiness (47/100 against 21/100), domain rating (63/100 against 41/100), funding raised ($700M against $371M).
Read the full C4 Therapeutics review and pricing or the Caris Life Sciences review and pricing. You can also browse other C4 Therapeutics alternatives we track.